WTO TRIPS Waiver Alone Insufficient to Ensure Global Access to COVID-19 Medicines, Experts Warn
Despite calls for a temporary waiver on intellectual property rights to boost COVID-19 treatment availability, legal and practical barriers may limit its effectiveness, prompting…
The ongoing debate over intellectual property rights during the COVID-19 pandemic highlights the complex balance between incentivizing pharmaceutical innovation and ensuring equitable access to life-saving medicines. While South Africa and India have proposed a WTO TRIPS waiver to temporarily suspend IP protections on…